Abstract:Introduction: Urotensin II (UII) is an important vasoactive peptide involved in the pathogenesis of atherosclerosis. Monocytes/macrophages play important roles in every step of atherosclerosis. Although UII has a chemoattractant effect on monocytes, it is unclear whether UII regulates inflammatory responses in macrophages. The present study sought to explore whether UII can promote leukotriene B-4 (LTB4) production by macrophages.Material and methods: The mRNA expression level of LTB4 and 5-lipoxygenase were determined by real-time polymerase chain reaction. The protein level of LTB4 and 5-lipoxygenase expression was assayed by enzyme-linked immunosorbent assay and Western blot, respectively. Western blot analysis was also employed to determine the phosphorylated forms of Akt. Reactive oxygen species (ROS) level was detected by the fluorescent probe 2', 7'-di-chlorofluorescin diacetate and fluorescence intensity was measured with a multiwell fluorescence plate reader.Results: Urotensin II promoted LTB4 release and increased 5-lipoxygenase expression in a concentration- and time-dependent manner in RAW264.7 cells. Leukotriene B4 production and 5-lipoxygenase expression were decreased by blocking the UII receptor (UT) with urantide, eliminating ROS with N-acetylcysteine and diphenyliodonium, and inhibiting Akt phosphorylation with LY294002. UII significantly elevated ROS production, whereas urantide, N-acetylcysteine and diphenyliodonium substantially attenuated this effect. UII also enhanced Akt phosphorylation significantly, and this effect was potently inhibited by urantide, N-acetylcysteine, diphenyliodonium and LY294002.Conclusions: Urotensin II may promote 5-lipoxygenase expression and LTB4 release in RAW264.7 macrophages via UT-ROS-Akt pathways. These results indicate that UII may participate in macrophage activation and suggest a potential new mechanism underlying atherosclerosis.

Urotensin Ii Promotes Secretion Of Ltb4 Through 5-Lipoxygenase Via The Ut-Ros-Akt Pathway In Raw264.7 Macrophages

Urotensin II Promotes the Production of LTC4 in Rat Aortic Adventitial Fibroblasts Through NF-κB–5-LO Pathway by P38 MAPK and ERK Activations

Urotensin II Promotes Atherosclerosis in Cholesterol-Fed Rabbits

Urotensin II Enhances Advanced Aortic Atherosclerosis Formation and Delays Plaque Regression in Hyperlipidemic Rabbits

UrotensinⅡinduces upregulation of monocyte chemoattractant protein-1 expression in macrophages and its mechanism

[Angiotensin II Induces Toll-Like Receptor 4 Expression and Myeloperoxidase Activity in RAW264.7 Cells].

Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages

Angiotensin II induces the expression of c-reactive protein via MAPK-dependent signal pathway in U937 macrophages.

Urotensin II and urantide exert opposite effects on the cellular components of atherosclerotic plaque in hypercholesterolemic rabbits

Urotensin II Increases Foam Cell Formation by Repressing ABCA1 Expression Through the ERK/NF-κB Pathway in THP-1 Macrophages

Urotensin II Promotes the Proliferation of Endothelial Progenitor Cells Through P38 and P44/42 MAPK Activation.

[Central Reactive Oxygen Species Mediate Cardiovascular Effects of Urotensin II in Spontaneously Hypertensive Rats].

Autocrine Human Urotensin II Enhances Macrophage-Derived Foam Cell Formation in Transgenic Rabbits.

Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway

[Angiotensin II Increases the Expression of Lectin-Like Oxidize Low-Density Lipoprotein Receptor- 1 in Cultured Human Umbilical Vein Endothlial Cells]

Ulinastatin attenuates LPS-induced inflammation in mouse macrophage RAW264.7 cells by inhibiting the JNK/NF-κB signaling pathway and activating the PI3K/Akt/Nrf2 pathway

Angiotensin II Induces Inflammatory Response Partly Via Toll-Like Receptor 4-Dependent Signaling Pathway in Vascular Smooth Muscle Cells.

The Role of Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP1) in Angiotensin II-induced Macrophage Apoptosis and Vulnerable Plaque Formation.

Alteration of Vascular Urotensin Ii Receptor in Mice with Apolipoprotein E Gene Knockout

Angiotensin Ii Upregulates Endothelial Lipase Expression Via The Nf-Kappa B And Mapk Signaling Pathways

Role of Reactive Oxygen Species in Angiotensin II: Induced Receptor Activator of Nuclear Factor-Κb Ligand Expression in Mouse Osteoblastic Cells.